terazosin has been researched along with Urethral Obstruction in 2 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Urethral Obstruction: Partial or complete blockage in any part of the URETHRA that can lead to difficulty or inability to empty the URINARY BLADDER. It is characterized by an enlarged, often damaged, bladder with frequent urges to void.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Velasco, C | 1 |
| Guarneri, L | 1 |
| Leonardi, A | 1 |
| Testa, R | 1 |
| Onur, R | 1 |
| Tasdemir, C | 1 |
| Seckin, D | 1 |
| Ilhan, N | 1 |
| Kutlu, S | 1 |
| Akpolat, N | 1 |
2 other studies available for terazosin and Urethral Obstruction
| Article | Year |
|---|---|
Effects of intravenous and infravesical administration of suramin, terazosin and BMY 7378 on bladder instability in conscious rats with bladder outlet obstruction.
Topics: Administration, Intravesical; Adrenergic alpha-Antagonists; Animals; Female; Infusions, Intravenous; | 2003 |
Combined use of melatonin and terazosin restores bladder contractility in rabbits with partial outlet obstruction.
Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Drug Therapy, Combination; Humans; Melatonin; M | 2008 |